Searchable abstracts of presentations at key conferences in endocrinology

ea0091p12 | Poster Presentations | SFEEU2023

A rare case of Hyperparathyroidism Jaw Tumour Syndrome without jaw tumours

Mulholland Sarah , Lewis Alex

Case History: A 19-year-old female presented with painful left shoulder after slipping whilst doing press-ups. Plain x-ray showed a proximal humeral fracture, as well as a large bone cyst raising concerns of a pathological fracture. She had no past medical history and was not taking any regular medications. On further questioning she did complain of a 2 year history of bilateral painful shoulders and left knee pain. Family history was significant for her father suffering prima...

ea0091p22 | Poster Presentations | SFEEU2023

Cystic Prolactinoma unmasking Meningoencephalocele: When medical treatment leads to surgery

Greenhalgh Sophie , Lewis Alexander

Case history: 21-year-old male presented in November 2006 with visual loss, headaches and fatigue. No previous past medical history. Visual field testing confirmed a left temporal hemianopia with right temporal upper quadrantanopia.Investigations: Brain imaging revealed a large macroadenoma with suprasellar and lateral extension. Hormone testing demonstrated abnormalities in TSH 5.13 mU/L, Free T4 7.1 pmol/l, random Cortisol 64nmol/l and Testosterone 2.3...

ea0044ep114 | (1) | SFEBES2016

Thymic hyperplasia in Graves’ disease: case presentation and review of current literature

Lewis Alex , Cheer Kelly

A 37-year-old Nigerian lady was referred to the endocrinology clinic with worsening dyspnoea, weight loss, poor sleep and palpitations over the preceding few months. She had a past history of depression treated with citalopram. She was clinically and biochemically thyrotoxic with a TSH <0.01 μ/l [0.4–5] and free T4 49.3 pmol/l [9–19]. TSH receptor antibodies were positive. She was commenced on carbimazole 40 mg once daily and propranolol 40 mg twi...

ea0030p35 | (1) | BSPED2012

Late endocrine effects of non-craniopharyngioma, non-glioma brain tumours: descriptive analyses of patients referred to late-effects service

Lewis Gareth , Spoudeas Helen

Background: Children with brain tumours are known to be at risk of late neuroendocrinopathies due to anatomical and treatment disturbances to central pituitary function.Aims: To provide a descriptive analysis of a cohort of children with such tumours, referred to the late-effects neuroendocrine service at UCLH. It aims to describe the types of tumour, treatment and current endocrine morbidity of this cohort.Methods: Cases were iden...

ea0024p40 | (1) | BSPED2010

An audit on the process of transition from the paediatric diabetes service to the adult service at the University Hospital of Wales

Lewis V , Wareing L

Introduction: The period of adolescence is a difficult time for most people and is the time when transition from the paediatric diabetic service to the adult occurs; therefore a smooth transition is essential. The National Service Framework for Diabetes identified transition from paediatric care to adult as an area where protocols could support better care. Placing emphasis on the transition services may help in ensuring effective long-term control and health improvement.<...

ea0003oc47 | Neuroendocrinology | BES2002

A2B adenosine receptors mediate the adenosine-induced increase in cell growth and IL-6 expression in pituitary folliculostellate cells

Rees D , Lewis M , Lewis B , Scanlon M , Ham J

Coordinated interaction between the immune and neuroendocrine systems is of key importance in regulating the host's response to inflammation and anoxic stress. Adenosine, released under such conditions in high concentration, modulates a number of inflammatory processes and can regulate the activity of the hypothalamo-pituitary-adrenal (HPA) axis. Although adenosine receptors (ARs) have been described in the pituitary gland, the distribution of the receptor subtypes (A1, A2A, A...

ea0091wf11 | Workshop F: Disorders of the parathyroid glands, calcium metabolism and bone | SFEEU2023

A rare case of atypical parathyroid tumor with atypical presentation

Aye Thant Aye , Lewis Alexander

Introduction: Primary hyperparathyroidism is usually caused by a parathyroid adenoma (80-85%), occasionally by primary parathyroid hyperplasia (10-15%), and rarely by atypical parathyroid tumor (APT) or carcinoma (<1%). APT reflects parathyroid neoplasm of uncertain malignant potential which poses a challenge for differential diagnosis with parathyroid carcinomas. Most patients exhibit strong symptomatology of hypercalcemia at presentation shared with the benign causes of ...

ea0094p187 | Bone and Calcium | SFEBES2023

Hyperparathyroidism in the young: A case and investigation pathway

Aye Thant Aye , Lewis Alexander

Introduction: Primary hyperparathyroidism may be sporadic or occur as part of a genetic predisposition. Inactivation of CDC73 tumour suppressor gene can cause hyperparathyroidism-jaw tumour (HPT-IJ) syndrome, parathyroid carcinoma or familial isolated hyperparathyroidism (FIHP).Case details: We report a 26 year old gentleman, previously fit and well who was found to have hypercalcemia on a routine testing. Renal ultrasou...

ea0065p75 | Adrenal and Cardiovascular | SFEBES2019

Review of the adrenal surgeries at East Sussex Hospitals Trust over 2 years

Kumar Sathis , Lewis-Morris Timothy , Rimington Peter

Introduction: Prior to 2015 there was no pathway for adrenal masses. An Adrenal MDT was started to discuss all the adrenal nodules (except for suspected phaechromocytoma and adrenal carcinoma) to improve the service for this cohort of patients. This audit is a review of the impact of this intervention.Methods: Data was collected between April 2016 and March 2016 for all adrenalectomies performed at East Sussex Hospitals Trust. Data was collected from the...

ea0062p46 | Poster Presentations | EU2019

Thyroid Dysfunction induced by Alemtuzumab; a monoclonal antibody used in the treatment of multiple sclerosis

Hamill Connor , Courtney Hamish , Lewis Anthony

Case History: Case 1: A 37-year-old lady with relapsing-remitting multiple sclerosis was initiated on Alemtuzumab and symptoms of sweats and heat intolerance arose. Hyperthyroidism was confirmed with free T4 30.1 pmol/l (12–22) and suppressed TSH. Symptoms settled without antithyroid medication and within 2 months T4 had fallen to 10.2 pmol/l with TSH 6.95 mIU/L. After a further 6 weeks T4 was 9.8 with TSH 20.35 and levothyroxine was initiated. Anti-TPO was raised at 442 ...